Steward Partners Investment Advisory’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,000
Closed -$405 4284
2025
Q1
$405 Hold
5,000
﹤0.01% 3877
2024
Q4
$3.73K Hold
5,000
﹤0.01% 3465
2024
Q3
$6.1K Buy
5,000
+3,000
+150% +$4.78K ﹤0.01% 3123
2024
Q2
$4.14K Buy
+2,000
New +$4.71K ﹤0.01% 3106

Steward Partners Investment Advisory's OMGA Position: Q2 2025 in Review

Steward Partners Investment Advisory sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q2 2025, closing a stake of 5,000 shares — an estimated $405 sold.

Steward Partners Investment Advisory first reported a position in OMGA in Q2 2024 and held it in 4 quarters. The position peaked at $6.1K in Q3 2024. 1 fund tracked by Wall St. Rank holds OMGA as of Q2 2025.

  • Steward Partners Investment Advisory reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 5,000 Omega Therapeutics, Inc. Common Stock shares in Q2 2025, an estimated $405.
  • Steward Partners Investment Advisory first reported a position in Omega Therapeutics, Inc. Common Stock in Q2 2024 and held it in 4 quarters.
  • Steward Partners Investment Advisory's Omega Therapeutics, Inc. Common Stock position peaked at $6.1K in Q3 2024.
  • 1 fund tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q2 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2025, filed 12 Aug 2025.